ESCAPE FROM ISOANTISERUM INHIBITION OF LYMPHOCYTE-MEDIATED CYTOTOXICITY by Faanes, R. B. et al.
ESCAPE  FROM  ISOANTISERUM INHIBITION  OF 
LYMPHOCYTE-MEDIATED  CYTOTOXICITY* 
BY R.  B.  FAANES,  Y.  S.  CHOI,$  AND R.  A.  GOOD 
(From  the  Pathology  Research  Laboratories,  Variety  Club  Heart  Hospital,  and  the 
Department of Pediatrics,  University  of Minnesota, Minneapolis, Minnesota 55455) 
(Received for publication 7 September 1972) 
Lymphocytes  derived  from  animals  immunized against  alloantigens exhibit  in 
vitro cytotoxicity for target cells carrying the respective isoantigen (1). This cytotoxic 
activity is mediated by theta-bearing (thymus-derived) lymphocytes (T cells) 1 (2, 3). 
The  accumulated evidence indicates that  the  cellular immune response  to  an  iso- 
antigen or tumor cell exists concomitantly  with isoantibodies secreted by bone marrow- 
or bursa-derived cells  (B cells)  that interfere with the in vitro cytotoxic activity of 
immune T cells (1, 4). It is now possible to quantitate the cytotoxic activity of sensi- 
tized lymphocytes through the use of 51Cr release from labeled target cells, a procedure 
developed by Brunner et al. (1) and Holm and Perlman (5). 
Using what  we  believe to  be  a  more  sensitive adaptation of  the  Brunner 
assay system (6),  we have found that isoantiserum inhibition of lymphocyte- 
mediated cytotoxicity (LMC) is not static. The isoantiserum blocking of LMC 
decreases significantly during our 4-h assay. This decrease in blocking activity, 
which  is  evidenced  by  an  increase  of  40-60%  in  the  specific  51Cr released, 
occurs in the presence of excess antiserum. These results are best understood 
in terms of antigenic modulation on the target cell (7). 
Materials and Methods 
Cell Lines  and  Culture Conditions.--The  P-815-X2 mastocytoma  (8) was obtained from 
Dr. T. Brunner and was maintained by weekly transfer of ascitic fluid in DBA/2J mice (Jack- 
son Laboratory, Bar Harbor, Maine). Every 6-8 wk aseptically aspirated ascitic fluid served as 
inoculum for a tissue cultme cell line. The in vitro culture cells were maintained in Dulbecco's 
modified Eagle's medium with 10% calf serum (CS) (9), at 37°C, in a humidified 15% CO2-85% 
air incubator.  The cell concentration was maintained  at 1-3  X  105 cells/ml.  Under these 
conditions a generation time of 10 h was routinely recorded (Fig. 1). 
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Preparation of Sensitized Spleen Cells and Antimastocytoma Isoantisera (IS).--Mastocytoma 
cells for immunization were collected by aspirating ascitic fluid from DBA/2J mice. The cells 
were washed by centrifugation and counted in Alsever's solution (10). For primary immuniza- 
tion, 3  X  107 cells  (1) were injected intraperitoneally with 109 pertussis organisms into 6-8- 
wk old C57/BL6  male mice (Jackson Laboratory), 9-12  days after the primary immuniza- 
tion, spleens removed from recipients were minced in RPMI medium (Associated Biomedic 
Systems, Inc., Buffalo,  N.  Y.)  containing 10%  CS  and homogenized with a  loosely fitting 
Tefon homogenizer. The spleen cell suspensions were passed through a stainless steel screen 
(no.  200 mesh) and centrifuged at 350 g for 10 min. The pellet was suspended in the same 
medium, and lymphocytes were purified by Ficoll-Hypaque centrifugation, as described by 
Thorsby and Bratlie (11). The gradient purified lymphocytes  were then collected by centrifuga- 
lion, washed with fresh media, and used in the cytotoxic assay. Spleen cells prepared in this 
manner were 85-99% viable as determined by trypan blue exclusion  (12). All procedures were 
carried out at room temperature. 
Isoantiserum was prepared in C57/BL6 mice by injecting 3  X  107 mastocytoma cells  14 
days after the primary injection and weekly thereafter for a total of five doses. 7 days after the 
final booster, the mice were bled from the axillary area. Sera were pooled and decomplemented 
by incubating at 56°C for 45 min. Sera prepared in this manner had hemagglutination titers of 
1,056, as determined by the method of Stimpffing (13). 
Labeling of Mastocytoma Cells with 51Cr.  Aliquots of  the stock cultures were  routinely 
diluted to 1 X  104 cells/ml and allowed to grow 48 h to assure the use of healthy exponentially 
growing cells in the experiment (Fig.  1). Cells were collected by centrifugation at 350 g for 3 
min. The pellets, containing approximately 5 X  106 cells, were suspended in 1.0 ml of RPMI 
medium with 10%  CS containing 0.25  /~g ionic  51Cr (specific activity 300  ~  400  #Ci/~zg) 
(Rachromate injection; Abbott Laboratories, North Chicago,  Ill.). The cell suspension was 
lightly gassed with CO_~ before a 45-rain incubation at 37°C. 
After incubation, the entire reaction mixture was layered on RPMI medium  containing 
20% CS and centrifuged at 200 g for 3 rain. Sedimentation of the cells through 20% CS at slow 
speed was repeated five times. This procedure proved to be the most efficient means of getting 
the background to 5-10~. of the total releasable counts. It consistently produced  a specific 
activity of 1.2-2.0  X  104 cpm/10  '~ cells with a viability near 100%, as determined by  trypan 
blue exclusion (12). (Unless specified, all manipulations were carried out at room temperature.) 
Cytotoxic Assay.--Spleen and ~lCr-labeled  mastocytoma cells were combined in equal pro- 
portions. 1 ml of the celi suspension containing 10 z mastocytoma cells and 0.1-I  X  107 spleen 
cells was incubated at 37°C, in a humidified incubator, in 35-ram plastic Petri dishes (Falcon 
Plastics, Los Angeles, Calif.) on a rocking platform (6 cycles/rain) (4). 
For measuring the cytotoxic effect, chromium released into the culture medium was moni- 
tored as follows.  At each sample time, the entire reaction mixture from one Petri dish was 
transferred to a centrifuge tube. The cells were pelleted at 450 g for 10 rain. A measured aliquot 
of the supernatant was transferred to counting tubes, and the radioactivity was determined by 
a Nuclear-Chicago gamma scintillation counter (Nuclear-Chicago, Des Plaines, Ill.). The total 
releasable count of the reaction mixture was determined by adding 2.0 ml of distilled water to a 
pellet of a known volume of the reaction mixture removed at the start of the assay. This proce- 
dure released 80-90~7~ of the bound '~lCr. The percent specific '~lCr release was calculated ac- 
cording to the method of Brunner et al.  (1). 
RESULTS 
Optimal  Conditions  for  Maximal  Lymphocyte-Mediated  Cyloloxicity.--In 
vitro  assay methods using  ~Cr  release from labeled  target  cells have  proved 
to  be  very  useful  in  measuring  cvtotoxic  activity  of  sensitized lymphocytes R.  B.  FAANES,  Y.  S.  CHOI~ AND  R.  A.  GOOD  173 
(5, 6). In order to study the effect of isoantibodies on the cytotoxic activity of 
sensitized lymphocytes, we modified the previously described method  (1)  to 
improve the sensitivity and reproducibility of the assay system. 
First, conditions were sought that gave maximal SlCr uptake with the least 
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FIG. 1.  Uptake and spontaneous release of 51Cr during the growth cycle of mastocytoma. 
Mastocytoma ceils were inoculated to a  density of 5  X  10  ~ cells/ml in Dulbecco's modified 
Eagle's medium at the start of the experiments. At the times indicated by points on the graph, 
samples were withdrawn. The cell number per milliliter was determined using a  hemacytom- 
eter; labeling conditions and the determination of the percent spontaneously released counts 
are described under Materials and Methods. Cell  density (O);  51Cr uptake/10 s cells  (A); 
degree of spontaneous 51Cr release in 3 h  (0). 
amount of spontaneous cell lysis. A culture of mastocytoma cells was started at 
low density (i.e.  5 X  l0  s cells/ml) for establishing a growth curve. At various 
times  samples  were  withdrawn  for cell number per milliliter  determination, 
~lCr uptake,  and  spontaneous  cell lysis in 3  h.  The  mastocytoma  grew  ex- 
ponentially with  a  doubling  time  of  10 h  (Fig.  1).  There was  no  difference 
between exponentially growing and stationary phase mastocytoma cells with 174  TIlE  EFFECT  OF  ISOANTISERUM  ON  Llk[C 
respect to 5~Cr uptake.  However, the extent of spontaneous cell lysis became 
very pronounced in cells harvested from the stationary phase of growth. It was 
also  found  that  stationary  phase  cells  were  significantly  less  susceptible  to 
specific lymphocyte mediated  lysis.  (This  phenomenon  has recently been re- 
ported  to  exist  in  several  mammalian  tumors  [14].)  Hence,  with  the  use  of 
exponentially growing target cells,  complete lysis,  as indicated  by 100%  spe- 
cific 5~Cr release, was consistently obtained within 4 h, the lymphocyte to target 
cell ratios being as low as 13/1  (Table I). 
Second,  we  found  that  using  RPMI  1640  medium  in  place  of Dulbecco's 
modified Eagle's medium (9)  and gently rocking the reaction mixtures greatly 
enhanced the efficiency of lymphocyte-mediated cytotoxicity (4). 
Inhibition  of Lymphocyte-Mediated Cytotoxicity by  Isoantiserum.--Previous 
TABLE  I 
Effect of Lymphocyte~Target Cell Ratio on the Kinetics of ~lCr Release* 
Lymphocyte/target  cell 
ratio 
Specific ~lCr  release 
--  90 min~  180 min  270 rain 
1/1  2  15  23 
7/1  19  60  78 
13/1  32  78  100 
221/1  52  86  100 
43/1  53  94  100 
100/1  87  90  100 
* incubations were done in RPMI 1640 medium containing 10% CS. 
Incubation period. 
reports (1, 4) have indicated  that heat-inactivated tumor-specific isoantiserum 
effectively inhibits  the  cytotoxicity  of  sensitized  lymphocytes  against  their 
respective target cells.  The results reported to date suggest that the observed 
inhibition is static. 
We studied the effect of isoantiserum on the cytotoxic activity of sensitized 
lymphocytes.  First,  an  experiment similar  to  that  of Brunner  et  al.  (1)  was 
carried out to determine the dose of pooled antisera that gave maximal inhibi- 
tion of LMC. Increasing amounts of heat-inactivated antiserum were added to 
incubation  mixtures containing  either sensitized  or normal  spleen cells.  Sam- 
ples were withdrawn at 90 rain, and the 5ICr released into the supernatant was 
determined. The control culture containing normal serum showed 86% specific 
lysis  whereas  that  containing  10%  sensitized mouse serum showed only 18% 
(Fig.  2,  curve A). Antiserum concentrations of 3% and 6% showed 42%  and 
30%  lysis,  respectively. The inhibitory  effect of the  antiserum  was found  to 
be  transient:  samples removed at  180  and  270  rain  (Fig.  2,  curves B  and C) R.  B.  FAANES~ Y.  S.  CHOI, AND  R.  A.  GOOD  175 
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FIG. 2.  Escape from isoantiserum  inhibition of sensitized lymphocyte-mediated target cell 
lysis. Increasing amounts of antimastocytoma isoantiserum  were added to 4 ml of reaction 
mixtures containing  1 X l0 T  sensitized or normal spleen cells and 1 X  105 51Cr-labeled target 
cells/ml. Total serum  concentration  in the reaction mixture was brought to  10% with de- 
complemented CS. The reaction mixtures were distributed into three 1-ml aliquots for sampl- 
ing at the times indicated: 90 rain  (curve  A); 180 rain  (curve  B); 270  min  (curve  C). Per- 
cent 51Cr release was  monitored as  described  under  Materials and  Methods.  Each  point 
indicates the average of three to five experiments. 
showed  a  significant time-dependent  decrease  in  the  inhibitory  effect  of  the 
isoantiserum. 
The blocking activity was found in a serum fraction precipitated with 33-55 % 
(NH4)2SO4  and  separated  with  the  7S  globulins on  Sephadex  G-200.  These 
results suggested that we were working with a blocking antibody similar to that 
reported by Brunner and colleagues (1). 
Several obvious explanations for the unblocking  (escape)  phenomenon  had 
to be considered. 
First, although the CS and IS were inactivated at 56°C for 45 min, the pos- 
sibility of  complement  arising  from  the spleen or mastocytoma cell popula- 
tion  and  causing  antibody-mediated  lysis had  to  be  investigated.  Table  II 
shows the results of the experiment testing this possibility. Neither decomple- 
mented  antiserum incubated  with  target  cells nor  IS  combined with  normal 
lymphocytes  and  target  cells  showed  significant  specific  51Cr release  over 176  THE  E~t~ECT  OF  ISOANTISERUM  ON  LMC 
TABLE  II 
Inability of Decomplemented Isoantiserum to Effect Cytotoxicity 
Contents of incubation mixture 
Specific ~lCr release* 
90mln  180min  270min 
Isoantiserum (IS):~  0 
IS plus normal spleen cells  0 
Normal mouse serum (NMS) plus sensitized spleen  51 
cells 
% 
0  0 
0  0 
84  90 
* The data represent the average of three experiments. 
:~ The serum concentration in the incubation mixtures was  10%, and  the lymphocyte/ 
target cell ratio was 100/1. 
background during  the  course  of  our  experiments.  Moreover,  100  /zg/ml  of 
carrageenan,  a  known  complement  inhibitor,  did  not  effect  the  unblocking 
phenomena.  These  data  argued  against  complement-mediated  cytotoxicity. 
At the same time, the antibody-induced cytotoxic effect of normal lymphocytes 
(B cells)  was found to be not significant in our assay system (15-17). 
Secondly, in vitro activation of macrophages in response to antigen-antibody 
complexes had to be considered as a cause of lysis of target cells in the presence 
of antiserum  (18, 19).  This  possibility was studied  in  the  following manner. 
The  sensitized  spleen  ce!ls  were  incubated  in  plastic  Petri  dishes  for 2  h  at 
37°C  in  a  humidified  incubator  to  separate  adhering  cells  from nonadhering 
cells.  The separated cells were  tested for their cytotoxic effect.  Adhering cells 
failed to exhibit a cytotoxic activity within 3 h. The nonadhering cells, however, 
exhibited the same cytotoxic activity as the original lymphocytes (Table III). 
The escape phenomenon was still  evident. 
Thirdly,  it  was felt  that  if  the  escape  phenomenon was  attributable  to  a 
minor  lymphocyte population,  reducing  the  lymphocyte to  target  cell ratio 
should dilute out such a population and abrogate the unblocking phenomenon. 
Table IV shows the results from experiments using three different lymphocyte 
to target cell  ratios.  It can be seen  that a  tenfold variation in lymphocyte to 
target  cell  ratio  had  no  appreciable  effect  on  the  unblocking phenomenon. 
These results implied  that the unblocking phenomenon was a  function of the 
target  cell  rather  than  of  the  sensitized  lymphocytes,  suggesting  that  the 
target cells  became refractory to isoantibody but sensitive to LMC as the in- 
cubation continued. 
Escape from Antiserum Inhibition of LMC in the Presence  of Excess Isoanti- 
serum.--The escape from isoantiserum inhibition of the LMC may be a conse- 
quence of a nonspecific inactivation of the antiserum in our assay system. This 
possibility  was  investigated  by  adding  fresh  isoantiserum  to  the  incubation 
mixture  at  the  beginning of unblocking or by checking for residual  blocking 
activity in the supernatant as follows: As shown in Table V, once unblocking R.  B.  FAANES,  Y.  S.  CHOI~  AND  R.  A.  GOOD  177 
TABLE III 
Escape from  Isoantiserum  Inhibition  after  Removal  of  Adhering  Cells 
Specific SlCr release 
60 min  120 min  180 min 
% 
Spleen cells 
CS  27  77  86 
IS*  6  30  48 
Nonadhering cells 
CS  2  89  100 
IS*  10  28  54 
* 6%  isoantiserum brought to 10% serum with CS. In each case the lymphocyte/target 
cell ratio was 50/1. The data represent the average of two experiments. 
TABLE IV 
The Effect of Lymphocyte~Target  Cell Ratio on the Escape Phenomena* 
Lymphocyte/target cell 
ratio 
Specific S~Cr release 
90 min  180 min  270 rain 
% 
13/1  4  17  50 
43/1  3  28  68 
100/1  11  37  73 
* The data,  which represent  the average  of  three  experiments,  are  6%  isoantiserum 
brought to 10% serum with CS. 
TABLE  V 
Effect of Additional  Isoantiserum on LMC* 
Specific 51Cr release 
90 min  180 rain  270 rain 
% 
Normal mouse serum  10  42  62 
Isoantiserum  15  48  70 
* Target cell-lymphocyte suspensions  were incubated  with 6~  isoantiserum for 75 min, 
at which  time an  additional  5~o  NMS  or 5% IS were added  to  the incubation  mixtures. 
The data represent the average of three experiments. 
had  been  initiated,  the  addition  of  fresh  antiserum  did  not  cause  blocking. 
Furthermore,  blocking  activity  was  still  detected  in  the  culture  medium 
after  180 min of incubation  in  the presence of absence  of mastocytoma  (Table 
VI).  These  data  support  the  conclusion  that  the  target  cell  is  somehow  ca- 
pable  of  becoming  refractory  toward  antibody directed at its surface determi- 
nants while it remains sensitive to LMC. 
We studied whether tumor cell metabolism was required for the escape from 178  THE  EFFECT  OF  ISOANTISERUA~ ON  LMC 
TABLE VI 
Residual Blocking Activity in Culture Supernatant* 
Preincubation period 
Incubation period  30 min  90 rain  180 rain  Control:~ 
+M  --M  - +M  --M  +M  --M 
90 min  20  20  22  26  23  24  57 
180 min  45  65  59  55  53  54  85 
* 8% antiserum incubated for 30 min, 90 rain, and 180 rain in the presence or absence of 
mastocytoma cells (-t-M, --M). At the times indicated, the cultures were spun down and 
the supernatants were checked for blocking acfiving by incubating with fresh mastocytoma 
cells and sensitized spleen cells. ~mples were removed at 90 min and 180 min, and percent 
specific 51Cr release was determined. The lymphocyte/target cell ratio was 100/1. 
The control reaction mixture contained 10% NMS. 
the inhibition of antiserum. A method of manipulating biosynthesis in the target 
cell without affecting spleen cell cytotoxicity was sought to confirm this idea. 
The Effect of Temperature  on the Kinetics of Escape from Antiserum Inhibition 
of  LMC.--Previous  studies  indicated  that  membrane  biosynthesis  could  be 
affected by low  temperature  (20,  21).  If the escape from IS inhibition were  a 
function of target cell membrane metabolism, a  significant temperature  effect 
on the kinetics of escape from antiserum inhibition of LMC would be expected. 
Chromium-labeled mastocytoma cells were preincubated at 0°C  for  15  rain 
before the addition of 6%  IS. The cell suspension was  then  incubated  an  ad- 
ditional 30-50 min at 0°C in an ice-water bath. The antibody-coated cells were 
washed  at  4°C  with  serum-free  RPMI  medium.  The  washed  cells were  then 
divided and placed in two  aliquots for incubation, one  at 37°C  and  the other 
at  0°C,  for  40  min.  At  the  end  of  the  incubation,  both  cultures were equil- 
ibrated  to  37°C  and  spleen  cells were  added  to  produce  cvtotoxic  activity. 
As shown in Fig. 3,  the cells incubated at 0°C showed  a  reproducible 30-40 
rain lag in escape compared with  the cultures incubated continually at 37°C. 
This  result  supports  the  hypothesis  that  active  membrane  metabolism  of 
target cells is involved in the escape phenomenon. 
DISCUSSION 
We  have  found  that  sensitized  lymphocytes  are  capable  of  overcoming 
isoantiserum (IS) inhibition of their cytotoxic activity (Fig. 2). We think that 
the escape from the blocking effect of IS is a  consequence of antigenic modula- 
tion  on  actively metabolizing  mastocytoma cells.  This conclusion is derived 
from  the  experimental evidence outlined below:  (a) The  escape phenomenon 
is  independent  of  complement-mediated  cytotoxicity  because  cell  lysis  is 
negligible unless sensitized lymphocytes are added  (Table II).  (b) There is no 
evidence of activation of normal lymphocytes  (B  cells) mediated by antigen- R.  B.  FAANES,  Y.  S.  CHOI~  AND  R.  A.  GOOD  179 
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FIG. 3.  Effect of low temperature  incubation on the rate of escape of LMC from isoanti- 
serum inhibition.  51Cr-labeled  mastocytoma cells (sp act  =  1.4  )<  104 cpm/105 ceils) sus- 
pended in serum-free RPMI 1640 were cooled in an ice-water bath for 15 min. Aliquots of the 
cooled cells were added to equal volumes of cooled medium containing 6% isoantiserum or 
normal mouse serum (NMS). The cells were allowed to incubate in the presence of the mouse 
serum for 30-50 min at 0°C. The antibody-coated cells were then collected and washed with 
serum-free RPMI by centrifugation at 350 g foi 10 rain at 0°C. The washed cells were divided 
into two groups: one was maintained  at 0°C while the other was incubated at 37°C. At the end 
of a 40-min incubation  at their respective temperatures, both suspensions were equilibrated to 
37°C for 10 rain, and the normal or sensitized spleen cells were added. The percent specific 
51Cr release was determined as described under Materials and Methods. Normal mouse serum 
at 0°C and 37°C (©) ; 6% isoantisera at 37°C ( • ); 6% isoantisera at 0°C (A). 
antibody complexes  (Tables II and III)  (15-17).  Moreover,  such nonspecific 
mechanisms of  lymphocyte activation require 8-24 h,  which  is much  longer 
than the incubation period used in our experiments. (c) Incubating antibody- 
coated target cells at 0°C produces a  significant lag in the escape from IS in- 
hibition (Fig. 3). 
Brunner et al.  (1) reported that the degree of inhibition by IS of LMC was 
related to  the IS concentration in the incubation mixture. Our results in the 
early phase of incubation are in agreement with theirs on this point. However, 
we  could demonstrate a  time-dependent increase of LMC  in the  presence of 
excess antibody (Fig. 2). 
Chang et  al.  (22)  demonstrated that  the  amount of  antibody adsorbed  to 
strain A leukemia cells was proportional to the concentration of antisera in the 
reaction mixture. This study also revealed that 30% of the cell-bound antibody 
was released into the medium in an unaltered form within 2 h  after removal of 
excess antibody. 180  THE  EFFECT  OF  ISOANTISERU~I ON  LMC 
The possibility of unmasking of antigenicity as a consequence of antibody re- 
lease from the  target cells must  be considered as  an  explanation for our ob- 
servation. It is assumed that antibody released, unaltered, from the cell surface 
(22) is in equilibrium with the cell-bound antibody if antibody is not limiting, 
as was the case in our experiments. If such an assumption is correct, our obser- 
vation could be a  result of competition between antibody and T  cells on the 
target cells. The irreversible escape from IS inhibition (Tables V and VI) could 
be a consequence of a significantly higher affinity of T  cells for the target cells 
than for the respective antibody. 
Several  investigators  have  reported  evidence  that  fluidity of  lymphocyte 
membranes  may provide an  escape from complement-mediated cytotoxicity. 
Maloney virus-transformed lymphoma cells lose the capacity to be destroyed 
by antibody during  certain  phases  of  the  cell  cycle  (23).  This  complement 
refractory period was found to be directly proportional to the doubling time 
of the lymphoma cell line. Similarly, Takahashi et al. (24) and Lesley, Kettman, 
and  Dutton  (25)  reported,  respectively,  that  melanoma  and  thymus  cells 
became  refractory  to  complement-induced  lysis  if  they  were  incubated  at 
37°C  with  antibodies  before  the  addition  of  complement.  Peripheral  blood 
lymphocytes  when  incubated  in  medium  containing  antiserum  against  the 
IgG surface components proceeded to form a polar cap and to engulf the cell- 
bound antibody within 5-10 min when incubated at 37°C  (21, 26). In view of 
these observations, we tried to explain our results as follows. 
We  think  that  actively metabolizing mastocytoma cells undergo a  surface 
antigen  modulation  that  leads  to  cells  becoming refractory to  the  blocking 
effect of isoantibody but sensitive to the cytotoxic effect of sensitized lympho- 
cytes. Unfortunately, direct demonstration of this conclusion requires an anti- 
metabolite  that  specifically  inhibits  mastocytoma  cell  membrane  mobility. 
Support for this hypothesis has been sought by experiments showing that the 
escape phenomenon is dependent on temperature.  The results obtained  (Fig. 
3)  are  reasonable  when  one  considers  that  the  "capping"  phenomenon  in- 
duced by antibody is also dependent on temperature (20,  21,  26).  It appears 
that  antigen recognition by specific T  cells is not readily affected by events 
that  significantly alter the  efficiency of the  humoral  antibodies produced  by 
B cells. 
The  Hellstr6ms  and  their co-workers (27)  have  reported  that  tumor cells 
incubated  with  blocking serum  regain  sensitivity  to  the  cytotoxic effects of 
immune  lymphocytes within  6  h  after incubation  of  the  target  cells  in  the 
absence of blocking serum. A  possible reason for the  disparity between  their 
work and ours with respect to the rate of regained susceptibility to LMC may 
be related to differences in the doubling times of different cell lines. 
In  light of these findings,  it is of current interest to determine whether or 
not the escape phenomenon we report is peculiar to an altogenic system. Our 
future studies will  be directed toward examining the capacity of the humoral 
system to successfully protect foreign tissue from immune surveillance. R.  B.  I~AANES, Y.  S.  CHOI, AND R.  A.  GOOD  181 
SUMMARY 
Isoantiserum  (IS)  inhibition  of  l~mphocyte-mediated  cytotoxicity  (LMC) 
was studied using an in vitro  5~Cr release  assay system.  In the early phase of 
incubation, LMC was competitively inhibited  by IS. However,  as the incuba- 
tion  continued,  LMC  irreversibly  overcame  IS inhibition  (the  "escape"  phe- 
nomenon). Addition of fresh antiserum  did not alter  the course of the escape. 
Low-temperature  incubation  of  isoantibody-coated  target  cells  delayed  the 
onset of the escape. 
We have excluded the possibility that the escape phenomenon is induced by 
complement or by LMC mediated by antigen-antibody complex. It is hypothe- 
sized  that  antibody  directed  toward  an  actively metabolizing  target  cell  in- 
duces an  alteration  in  the  cell membrane  that  alters  further  interaction  with 
the  antibody.  However,  sensitivity  to lymphocyte cytotoxicity is maintained. 
We wish to acknowledge the excellent technical assistance of Miss Mary Ann Morris. Dr. D. 
Kiszkiss did a critical review of this paper. The secretarial skills of Miss Judy Harrigan were 
most valuable in preparing the manuscript. 
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